Swiss Skincare Giant Galderma Gears Up for IPO

Galderma, a prominent player in the dermatology industry, has unveiled plans for an IPO on the Swiss Stock Exchange, signaling its intent to raise over £2 billion. This IPO is slated to be among Europe's largest this year, alongside Douglas.

The price range for Galderma's shares is set between 49 and 53 Swiss francs each. The offering comprises 40.5 million new shares and the sale of 277,000 existing shares. Additionally, an over-allotment option of up to 6.1 million existing shares is available, potentially swelling the total offer size to 2.3 billion Swiss francs (£2.1 billion) if fully exercised.

Galderma currently boasts stellar financials, with record sales of $4.1 billion last year and a 21% surge in core operating profits. The company has a diverse product lineup, spanning from acne treatments to wrinkle fillers.

Originally established through a collaboration between Nestle and L'Oréal, Galderma was acquired by the Swedish private equity firm EQT in 2019 for $10 billion. The IPO's offer period will extend until March 20th, positioning Galderma for a robust debut on the Swiss stock exchange.